| Style | Citing Format |
|---|---|
| MLA | Alimohammadi R, et al.. "Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates." npj Vaccines, vol. 7, no. 1, 2022, pp. -. |
| APA | Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Sattari Khavas D, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, ... Khoddami V (2022). Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates. npj Vaccines, 7(1), -. |
| Chicago | Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, et al.. "Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates." npj Vaccines 7, no. 1 (2022): -. |
| Harvard | Alimohammadi R et al. (2022) 'Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates', npj Vaccines, 7(1), pp. -. |
| Vancouver | Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, et al.. Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates. npj Vaccines. 2022;7(1):-. |
| BibTex | @article{ author = {Alimohammadi R and Porgoo M and Eftekhary M and Kiaie SH and Ansari Dezfouli E and Dehghani M and Nasrollahi K and Malekshahabi T and Heidari M and Pouya S and Alimohammadi M and Sattari Khavas D and Modaresi MS and Ghasemi MH and Ramyar H and Mohammadipour F and Hamzelouei F and Mofayezi A and Mottaghi SS and Rahmati A and Razzaznian M and Tirandazi V and Tat M and Borzouee F and Sadeghi H and Haji Mohammadi M and Rastegar L and Safar Sajadi SM and Ehsanbakhsh H and Bazmbar H and Baghernejadan Z and Shams Nouraei M and Pazooki P and Pahlavanneshan M and Alishah K and Nasiri F and Mokhberian N and Mohammadi SS and Akar S and Niknam H and Azizi M and Ajoudanian M and Moteallehiardakani MH and Mousavi Shaegh SA and Ramezani R and Salimi V and Moazzami R and Hashemi SM and Dehghanizadeh S and Khoddami V}, title = {Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates}, journal = {npj Vaccines}, volume = {7}, number = {1}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Alimohammadi R AU - Porgoo M AU - Eftekhary M AU - Kiaie SH AU - Ansari Dezfouli E AU - Dehghani M AU - Nasrollahi K AU - Malekshahabi T AU - Heidari M AU - Pouya S AU - Alimohammadi M AU - Sattari Khavas D AU - Modaresi MS AU - Ghasemi MH AU - Ramyar H AU - Mohammadipour F AU - Hamzelouei F AU - Mofayezi A AU - Mottaghi SS AU - Rahmati A AU - Razzaznian M AU - Tirandazi V AU - Tat M AU - Borzouee F AU - Sadeghi H AU - Haji Mohammadi M AU - Rastegar L AU - Safar Sajadi SM AU - Ehsanbakhsh H AU - Bazmbar H AU - Baghernejadan Z AU - Shams Nouraei M AU - Pazooki P AU - Pahlavanneshan M AU - Alishah K AU - Nasiri F AU - Mokhberian N AU - Mohammadi SS AU - Akar S AU - Niknam H AU - Azizi M AU - Ajoudanian M AU - Moteallehiardakani MH AU - Mousavi Shaegh SA AU - Ramezani R AU - Salimi V AU - Moazzami R AU - Hashemi SM AU - Dehghanizadeh S AU - Khoddami V TI - Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates JO - npj Vaccines VL - 7 IS - 1 SP - EP - PY - 2022 ER - |